We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Fortress Biotech
FBIO
$111M
| $250K | ﹤0.01% |
6,473
| – | – |
|
|
GNTY
902
DELISTED
Guaranty Bancshares
GNTY
| $249K | ﹤0.01% |
+8,338
| New | +$243K |
|
|
GTHX
903
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $249K | ﹤0.01% |
+9,427
| New | +$220K |
|
904
eBay
EBAY
$48.6B
| $246K | ﹤0.01% |
+6,811
| New | +$247K |
|
|
IO
905
DELISTED
ION Geophysical Corporation
IO
| $246K | ﹤0.01% |
28,385
+7,285
| +35% | +$63K |
|
|
CNSL
906
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $245K | ﹤0.01% |
+63,115
| New | +$242K |
|
907
Future Fuel
FF
$204M
| $244K | ﹤0.01% |
19,700
-700
| -3% | -$8.34K |
|
908
Lattice Semiconductor
LSCC
$17.6B
| $243K | ﹤0.01% |
12,700
| – | – |
|
909
United Natural Foods
UNFI
$3.01B
| $243K | ﹤0.01% |
+27,710
| New | +$223K |
|
910
Culp Inc
CULP
$45M
| $242K | ﹤0.01% |
+17,780
| New | +$273K |
|
|
LUMO
911
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $241K | ﹤0.01% |
10,574
+8,750
| +480% | +$125K |
|
912
Chemung Financial Corp
CHMG
$390M
| $240K | ﹤0.01% |
5,654
+803
| +17% | +$35.1K |
|
913
Universal Display
OLED
$3.71B
| $239K | ﹤0.01% |
1,158
-41,726
| -97% | -$7.88M |
|
|
MCBC
914
DELISTED
Macatawa Bank Corp
MCBC
| $234K | ﹤0.01% |
+20,988
| New | +$224K |
|
|
VOXX
915
DELISTED
VOXX International Corporation Class A
VOXX
| $232K | ﹤0.01% |
53,036
+4,896
| +10% | +$22.6K |
|
916
Aflac
AFL
$63.9B
| $229K | ﹤0.01% |
4,322
+252
| +6% | +$13.4K |
|
917
BayCom
BCML
$346M
| $229K | ﹤0.01% |
+10,079
| New | +$223K |
|
918
Spok Holdings
SPOK
$221M
| $227K | ﹤0.01% |
18,584
+4,400
| +31% | +$51.9K |
|
|
ROIC
919
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $226K | ﹤0.01% |
+12,800
| New | +$232K |
|
920
Rimini Street
RMNI
$408M
| $223K | ﹤0.01% |
57,574
+22,471
| +64% | +$90K |
|
|
NTGN
921
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $222K | ﹤0.01% |
188,277
+32,658
| +21% | +$52.2K |
|
922
Franklin Resources
BEN
$16.9B
| $219K | ﹤0.01% |
+8,440
| New | +$229K |
|
923
RingCentral
RNG
$4.05B
| $219K | ﹤0.01% |
+1,300
| New | +$214K |
|
|
GV
924
DELISTED
Goldfield Corporation
GV
| $219K | ﹤0.01% |
+61,554
| New | +$160K |
|
|
SAFE
925
Safehold
SAFE
$1.19B
| $218K | ﹤0.01% |
+3,089
| New | +$195K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.